A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
Clinical trial NCT07536061 · RECRUITING
Trial details
- NCT number
- NCT07536061
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-12
- Primary completion
- 2027-11-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.